Police Interactions Among Neuropathologically Confirmed Dementia Patients

Liljegren, Madeleine; Waldö, María Landqvist; Rydbeck, Robert; Englund, Elisabet

doi:10.1097/wad.0000000000000267

Cited by 23 publications

(23 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has previously been shown that patients with FTD interact more frequently with the police than patients with AD, most often owing to criminal behavior. 15 The present study confirms this finding, although the present sample included 22 additional patients with FTD. We believe that the growing population of individuals with dementia will make our findings relevant to the police and society at large.…”

Section: Discussionsupporting

confidence: 83%

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 83%

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…7,19 One recent study found 6.4% of persons with AD or FTD experienced police interactions initiated by behavior occurring before their diagnosis. 20 A Finnish study found 12.8% and 23.5% of men with AD and FTD, respectively, exhibited novel "criminal" behavior <3 years before diagnosis; 94% of behaviors were minor crimes (e.g., property/traffic offenses). 21 However, whether these behaviors resulted in incarceration is unclear.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of dementia and mild cognitive impairment before incarceration

Kuffel

Byers

Williams

et al. 2022

J American Geriatrics Society

View full text Add to dashboard Cite

Background: Accumulating evidence indicates that behaviors in Alzheimer's disease and related dementias could result in incarceration. Yet, the proportion of persons diagnosed with dementia and mild cognitive impairment (MCI) before they were incarcerated is largely unknown. By leveraging a national sample of mid-to late-life adults who were incarcerated, we determined the prevalence of dementia and MCI before their incarceration. Methods: In this current study, participants were Medicare-eligible U.S. veterans who transitioned from incarceration to the community in midto late-life from October 1, 2012, to September 30, 2018, after having been incarcerated for ≤10 consecutive years (N = 17,962). Medical claims data were used to determine clinical diagnoses of dementia and MCI up to three years before incarceration. Demographics, comorbidities, and duration of incarceration among those with dementia and MCI were compared to those with neither diagnosis.Results: Participants were >97% male, 65% non-Hispanic white, 30% non-Hispanic black, and 3.3% had a diagnosis of either dementia (2.5%) or MCI (0.8%) before their most recent incarceration. Individuals with MCI or dementia diagnoses were older, were more likely to be non-Hispanic white, had more medical and psychiatric comorbidities, and experienced homelessness and traumatic brain injury at higher rates than those with neither diagnosis. Average duration of incarceration was significantly shorter among those with MCI (201.8 [±248.0] days) or dementia (312.8 [±548.3] days), as compared to those with neither diagnosis (497.0 [±692.7] days) (p < 0.001). Conclusions: These findings raise awareness of the proportion of incarcerated persons in the United States who have a diagnosis of MCI or dementia before they are incarcerated. Improved understanding of pathways linking cognitive impairment to incarceration in mid-to late-life are needed to inform appropriateness of incarceration, optimization of health care, and prevention of interpersonal harm in this medically vulnerable population.

show abstract

“…Bertambahnya usia adalah faktor risiko terpenting untuk penyakit Alzheimer. Cidera kepala traumatis, depresi, penyakit kardiovaskular dan serebrovaskular, usia orang tua yang lebih tinggi, merokok, riwayat keluarga demensia, dan kehadiran alel APOE e4 diketahui meningkatkan risiko penyakit Alzheimer (Liljegren et al, 2018). Penyakit Alzheimer merupakan penyebab umum demensia yang ditandai dengan kegagalan kognitif ringan yang lama kelamaan menjadi berat hingga kehilangan fungsi kognitif (Bird, 2018).…”

Section: Pendahuluanunclassified

“…Cidera kepala traumatis, depresi, penyakit kardiovaskular dan serebrovaskular, usia orang tua yang lebih tinggi, merokok, riwayat keluarga demensia, dan kehadiran alel APOE e4 diketahui meningkatkan risiko penyakit Alzheimer. Pendidikan tinggi, penggunaan estrogen oleh wanita, penggunaan agen anti-inflamasi, dan latihan aerobik yang teratur diketahui dapat mengurangi risiko penyakit Alzheimer (Liljegren et al, 2018).…”

Section: Penyakitunclassified

Peran Neuroprotektor Astaxanthin dalam Pencegahan Penyakit Alzheimer

Arwin

Pratiwi

2020

Jurnal Ilmu Keperawatan Jiwa

View full text Add to dashboard Cite

Alzheimer merupakan penyakit neurodegeneratif yang terjadi secara bertahap dan progresif disebabkan oleh kematian sel neuron. Bertambahnya usia, cidera kepala traumatis, depresi, penyakit kardiovaskular dan serebrovaskular, usia orang tua yang lebih tinggi, merokok, riwayat keluarga demensia dapat meningkatkan risiko penyakit. Alzheimer tidak dapat disembuhkan, namun terdapat beberapa obat yang dapat mengatasi gejala simptomatis dari penyakit ini seperti inhibitor colinesterase dan N-metil D-aspartat (NMDA) parsial. Astaxanthin diketahui memiliki kandungan antioksidan dan antiinflamasi sepuluh kali lebih kuat dari kelompok karoten lain. Sehingga dapat menjadi neuroprotektor dengan meningkatkan pembersihan Aβ, melindungi viabilitas sel dari kerusakan yang disebabkan oleh Ab25-35, dan menghambat ekspresi IL-1b dan TNF-a. Tujuan dari tinjauan pustaka ini adalah untuk melaporkan temuan ilmiah terbaru tentang peran protektif dan kuratif astaxanthin pada otak manusia terhadap peradangan saraf, stres oksidatif dan, lebih umum, pada efek menguntungkan bagi pasien dengan gangguan neurodegeneratif seperti Alzheimer. Metode yang digunakan dalam artikel ini adalah penelusuran artikel melaui database NCBI dan Google Scholar. Tahun penerbitan sumber pustaka adalah dari tahun 1997 sampai tahun 2019 dengan 24 sumber pustaka. Tema yang dikumpulkan terkait dengan mekanisme neuroprotektor astaxanthin terhadap Alzheimer. Hasil dari sintesis artikel yang telah ditemukan yaitu astaxanthin dapat mencegah kerusakans sel otak sebagai pencegahan Alzheimer. Kata kunci: alzheimer, astaxanthin, neuroprotektor THE ROLE OF NEUROPROTECTOR ASTAXANTHIN AGAINST ALZHEIMER DISEASE ABSTRACTAlzheimer's is a neurodegenerative disease that occurs gradually and progressively caused by neuronal cell death. Increasing age, traumatic head injury, depression, cardiovascular and cerebrovascular diseases, higher age of parents, smoking, family history of dementia can increase disease. Alzheimer's cannot be cured, but there are some drugs that can overcome the symptomatic of this disease such as colinesterase inhibitors and partial N-methyl D-aspartate (NMDA). astaxanthin has higher antioxidant and anti-inflammatory properties than other carotene groups. Can be used as a neuroprotector by increasing Aβ regulation, protecting cell viability from damage caused by Ab25-35, and inhibiting the repair of IL-1b and TNF-a. The purpose of this literature evaluation is to report the latest scientific findings on the protective and curative role of astaxanthin in the human brain against nerve inflammation, oxidative stress and, more generally, on beneficial effects for patients with neurodegeneratives such as Alzheimer's. The method used in this article is article searching through the NCBI database and Google Scholar. Last year the library sources were from 1997 to 2019 with 24 library sources. The theme collected is related to the astaxanthin neuroprotector transition to Alzheimer's. The results of the synthesis of articles that have been found is that astaxanthin can prevent brain cell damage as against Alzheimer's. Keywords: alzheimer, astaxanthin, neuroprotector

show abstract

Police Interactions Among Neuropathologically Confirmed Dementia Patients

Abstract: The patterns of PIs differ between the frontotemporal dementia and Alzheimer disease patients. Knowledge about such differences may be of value for the police, the judiciary system, and the society in general.

Cited by 23 publications

References 24 publications

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort

Prevalence of dementia and mild cognitive impairment before incarceration

Peran Neuroprotektor Astaxanthin dalam Pencegahan Penyakit Alzheimer

Contact Info

Product

Resources

About